Note: Supplemental materials are not guaranteed with Rental or Used book purchases.
Purchase Benefits
Looking to rent a book? Rent Pharmaceutical Marketing: A Practical Guide [ISBN: 9781574911183] for the semester, quarter, and short term or search our site for other textbooks by Dogramatzis; Dimitris. Renting a textbook can save you up to 90% from the cost of buying.
Preface | p. xi |
The Author | p. xvii |
The Pharmaceutical Market | p. 1 |
The Healthcare Environment | p. 3 |
Health Care | p. 4 |
Overview of a Healthcare System | p. 4 |
Healthcare Reform | p. 7 |
Healthcare Regulation | p. 9 |
Major International Regulatory Bodies | p. 10 |
Need for Harmonization | p. 17 |
Further Reading | p. 18 |
The Pharmaceutical Industry Environment | p. 23 |
Pharmaceutical Industry Overview | p. 23 |
Associated Industries | p. 25 |
Environmental Forces | p. 26 |
Major Stakeholders | p. 27 |
Further Reading | p. 39 |
The Pharmaceutical Marketing Environment | p. 43 |
The Concept of Marketing: Products Satisfy Needs | p. 43 |
Marketing Management | p. 46 |
Pharmaceutical vs. Consumer Markets | p. 47 |
Ethical Considerations of Pharmaceutical Marketing | p. 47 |
The Marketing Mix | p. 49 |
Pharmaceutical Marketing Environment | p. 54 |
Product Management | p. 55 |
Further Reading | p. 59 |
Marketing Strategy | p. 61 |
What Is Marketing Strategy? | p. 63 |
Case Studies | p. 65 |
From Worldwide Vision to Local Tactics | p. 67 |
Definition of Marketing Strategy | p. 67 |
Strategic Planning | p. 69 |
Strategy vs. Tactics | p. 70 |
Further Reading | p. 71 |
Marketing Research | p. 73 |
Risks of Research | p. 74 |
Information Needs | p. 74 |
Marketing Information System | p. 75 |
Pharmaceutical Marketing Research Subjects | p. 76 |
Process and Methodology | p. 78 |
Primary and Secondary Data Sources | p. 80 |
Qualitative and Quantitative Methods of Research | p. 82 |
Further Reading | p. 86 |
Market Segmentation | p. 89 |
Market Definition | p. 89 |
The Concept of Market Segmentation | p. 92 |
Segmentation Methods | p. 92 |
Situational Analysis | p. 103 |
Types of Situational Analysis | p. 103 |
Situational Analysis Techniques | p. 104 |
Resource Analysis | p. 104 |
SWOT Analysis | p. 107 |
Performance Analysis | p. 109 |
Deriving the Key Success Factors | p. 109 |
Competitor Analysis | p. 109 |
Industry Attractiveness Analysis | p. 118 |
Definition of Industry's KSFs | p. 118 |
Competitive Intelligence | p. 119 |
Further Reading | p. 122 |
Positioning, Targeting, Profiling | p. 125 |
The Essence of Pharmaceutical Product Strategy | p. 126 |
Targeting | p. 126 |
Positioning | p. 127 |
Branding | p. 133 |
Profiling | p. 134 |
Further Reading | p. 135 |
New Product Development | p. 137 |
What Is a New Product? | p. 138 |
Pharmaceutical R&D Statistics | p. 139 |
Drug Discovery Methods | p. 140 |
The Role of Innovation | p. 141 |
The New Drug Development Process | p. 143 |
R&D Strategies | p. 150 |
R&D Benchmarking | p. 153 |
Importance of Time-to-Market | p. 154 |
Further Reading | p. 155 |
Product Life Cycle and Portfolio Management | p. 159 |
Patent Protection | p. 160 |
Conception and Product Development | p. 161 |
Introduction Phase | p. 162 |
Growth Phase | p. 164 |
Maturity Phase | p. 165 |
Decline Phase | p. 165 |
Product Withdrawal | p. 165 |
The Diffusion and Adoption Processes | p. 166 |
Strategies for Modifying Existing Products | p. 166 |
The Regulatory Life Cycle | p. 167 |
Portfolio Management | p. 167 |
Further Reading | p. 184 |
Competitive Strategies | p. 187 |
What Is a Competitive Strategy? | p. 187 |
Competitive Market Structures | p. 189 |
Competitive Forces | p. 190 |
Generic Competitive Strategies According to Weapon Used | p. 191 |
Generic Competitive Strategies According to Industry Position | p. 191 |
Generic Competitive Strategies According to Industry's Life Cycle Stage | p. 198 |
Market Signaling | p. 198 |
Ethical Pharmaceuticals vs. Generics | p. 200 |
Ethical vs. Generic Industry | p. 200 |
Market Erosion by Generics | p. 202 |
Drivers of Generic Growth | p. 203 |
Generics Strategies | p. 204 |
Antigeneric Strategies | p. 204 |
Further Reading | p. 206 |
Distribution Strategy | p. 209 |
Overview of Pharmaceutical Distribution | p. 211 |
Ethical Distribution Channel Members and Exchanges | p. 212 |
Ethical Distribution Channel Functions | p. 214 |
OTC Distribution | p. 216 |
Web Distribution | p. 218 |
Further Reading | p. 218 |
Distribution Strategy | p. 221 |
Key Channel Decisions | p. 221 |
Extent of Distribution | p. 222 |
Selecting a Distributor | p. 223 |
Logistics Functions | p. 224 |
Reverse Distribution of Expired Quantities | p. 227 |
Distribution-Associated Costs | p. 227 |
Parallel Exports | p. 228 |
Further Reading | p. 229 |
Pricing Strategy | p. 231 |
Pricing Concepts | p. 233 |
Elements of Price | p. 234 |
Multiple Pharmaceutical Product Prices in a Single Market | p. 237 |
Pharmaceutical Drug Financing | p. 237 |
Government Price Control | p. 238 |
Reimbursement | p. 238 |
Pharmacoeconomics | p. 241 |
Further Reading | p. 242 |
Pricing Strategy | p. 245 |
Price-Quality Strategy | p. 246 |
Setting a Price Objective | p. 247 |
Assessing Customer Demand | p. 248 |
Price Elasticity of Demand | p. 249 |
Knowing Your Costs | p. 252 |
Setting Pricing Policies | p. 253 |
Setting the Price Range | p. 254 |
Adjusting Product Prices within the Pharmaceutical Supply Chain | p. 258 |
Further Reading | p. 258 |
Communication Strategy | p. 261 |
Integrated Communications | p. 263 |
The Process of Communication | p. 264 |
The Prescribing Decision | p. 265 |
The Pyramid of Influence | p. 269 |
Communication Strategy | p. 269 |
Promotional Mix | p. 270 |
Promotional Planning | p. 272 |
Further Reading | p. 272 |
Personal Selling | p. 273 |
Personal Selling Tasks and Activities | p. 274 |
Selling Styles | p. 276 |
The Structured Sales Interview | p. 277 |
Sales Force Management | p. 278 |
Key Account Management | p. 283 |
Marketing to Sales Interaction | p. 285 |
Future Management Trends | p. 286 |
Further Reading | p. 286 |
Advertising | p. 289 |
Idiosyncrasies of Pharmaceutical Advertising | p. 290 |
Pharmaceutical Promotion Is Regulated | p. 290 |
Pharmaceutical Advertising Channels and Activities | p. 291 |
Advertising Planning and Development | p. 295 |
Further Reading | p. 299 |
Public Relations (PR) and Sales Promotion | p. 301 |
What Are Public Relations? | p. 302 |
Pharmaceutical PR Initiatives | p. 303 |
The PR Process | p. 305 |
Crisis Management | p. 307 |
Measuring the Effectiveness of PR | p. 307 |
Interaction with PR Agencies | p. 307 |
Sales Promotion | p. 308 |
Further Reading | p. 310 |
The Internet | p. 311 |
Pharmaceutical Industry and the Web | p. 312 |
Marketing Pharmaceuticals on the Web | p. 314 |
Developing an Interesting Web Site | p. 315 |
Evaluating the Effectiveness of the Web | p. 317 |
Drug Dispensing via the Web | p. 317 |
Further Reading | p. 318 |
Forecasting, Planning, and Evaluating | p. 319 |
Forecasting and Planning | p. 321 |
The Importance of Forecasting | p. 321 |
Forecasting Stages | p. 322 |
Forecasting Types | p. 324 |
Different Forecasting Scenarios | p. 324 |
Forecasting Methods | p. 324 |
Market Trends Analysis | p. 327 |
Forecast Evaluation Methods | p. 329 |
Core Planning Concepts | p. 329 |
Further Reading | p. 333 |
Evaluating Marketing Performance | p. 335 |
The Marketing Audit Process | p. 336 |
The Marketing Audit Tools | p. 339 |
Further Reading | p. 350 |
References and Appendices | p. 351 |
References | p. 353 |
Glossary | p. 357 |
Core Concepts on the Web | p. 361 |
Index | p. 369 |
Table of Contents provided by Rittenhouse. All Rights Reserved. |
The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.
The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.